IBDEI01A ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1225,1,2,0)
 ;;=2^Ultraviolet Therapy
 ;;^UTILITY(U,$J,358.3,1225,1,3,0)
 ;;=3^97028
 ;;^UTILITY(U,$J,358.3,1226,0)
 ;;=98940^^11^98^1^^^^1
 ;;^UTILITY(U,$J,358.3,1226,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1226,1,2,0)
 ;;=2^CMT; Spinal, one to two regions
 ;;^UTILITY(U,$J,358.3,1226,1,3,0)
 ;;=3^98940
 ;;^UTILITY(U,$J,358.3,1227,0)
 ;;=98941^^11^98^2^^^^1
 ;;^UTILITY(U,$J,358.3,1227,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1227,1,2,0)
 ;;=2^CMT; Spinal, three to four regions
 ;;^UTILITY(U,$J,358.3,1227,1,3,0)
 ;;=3^98941
 ;;^UTILITY(U,$J,358.3,1228,0)
 ;;=98942^^11^98^3^^^^1
 ;;^UTILITY(U,$J,358.3,1228,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1228,1,2,0)
 ;;=2^CMT; Spinal, five regions
 ;;^UTILITY(U,$J,358.3,1228,1,3,0)
 ;;=3^98942
 ;;^UTILITY(U,$J,358.3,1229,0)
 ;;=98943^^11^98^4^^^^1
 ;;^UTILITY(U,$J,358.3,1229,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1229,1,2,0)
 ;;=2^CMT; Extraspinal, one or more regions
 ;;^UTILITY(U,$J,358.3,1229,1,3,0)
 ;;=3^98943
 ;;^UTILITY(U,$J,358.3,1230,0)
 ;;=98925^^11^99^1^^^^1
 ;;^UTILITY(U,$J,358.3,1230,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1230,1,2,0)
 ;;=2^OMT, 1-2 body regions involved
 ;;^UTILITY(U,$J,358.3,1230,1,3,0)
 ;;=3^98925
 ;;^UTILITY(U,$J,358.3,1231,0)
 ;;=98926^^11^99^2^^^^1
 ;;^UTILITY(U,$J,358.3,1231,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1231,1,2,0)
 ;;=2^OMT, 3-4 body regions involved
 ;;^UTILITY(U,$J,358.3,1231,1,3,0)
 ;;=3^98926
 ;;^UTILITY(U,$J,358.3,1232,0)
 ;;=98927^^11^99^3^^^^1
 ;;^UTILITY(U,$J,358.3,1232,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1232,1,2,0)
 ;;=2^OMT, 5-6 body regions involved
 ;;^UTILITY(U,$J,358.3,1232,1,3,0)
 ;;=3^98927
 ;;^UTILITY(U,$J,358.3,1233,0)
 ;;=98928^^11^99^4^^^^1
 ;;^UTILITY(U,$J,358.3,1233,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1233,1,2,0)
 ;;=2^OMT, 9-10 body regions involved
 ;;^UTILITY(U,$J,358.3,1233,1,3,0)
 ;;=3^98928
 ;;^UTILITY(U,$J,358.3,1234,0)
 ;;=97810^^11^100^4^^^^1
 ;;^UTILITY(U,$J,358.3,1234,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1234,1,2,0)
 ;;=2^Acupunct w/o Stimul,15min
 ;;^UTILITY(U,$J,358.3,1234,1,3,0)
 ;;=3^97810
 ;;^UTILITY(U,$J,358.3,1235,0)
 ;;=97811^^11^100^5^^^^1
 ;;^UTILITY(U,$J,358.3,1235,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1235,1,2,0)
 ;;=2^Acupunct w/o Stimul,Ea Addl 15min
 ;;^UTILITY(U,$J,358.3,1235,1,3,0)
 ;;=3^97811
 ;;^UTILITY(U,$J,358.3,1236,0)
 ;;=97813^^11^100^2^^^^1
 ;;^UTILITY(U,$J,358.3,1236,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1236,1,2,0)
 ;;=2^Acupunct w/ Stimul,15min
 ;;^UTILITY(U,$J,358.3,1236,1,3,0)
 ;;=3^97813
 ;;^UTILITY(U,$J,358.3,1237,0)
 ;;=97814^^11^100^3^^^^1
 ;;^UTILITY(U,$J,358.3,1237,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1237,1,2,0)
 ;;=2^Acupunct w/ Stimul,Ea Addl 15min
 ;;^UTILITY(U,$J,358.3,1237,1,3,0)
 ;;=3^97814
 ;;^UTILITY(U,$J,358.3,1238,0)
 ;;=S8930^^11^100^1^^^^1
 ;;^UTILITY(U,$J,358.3,1238,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1238,1,2,0)
 ;;=2^Acupunct Electrostimulation
 ;;^UTILITY(U,$J,358.3,1238,1,3,0)
 ;;=3^S8930
 ;;^UTILITY(U,$J,358.3,1239,0)
 ;;=V41.0^^12^101^14
 ;;^UTILITY(U,$J,358.3,1239,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1239,1,1,0)
 ;;=1^V41.0
 ;;^UTILITY(U,$J,358.3,1239,1,2,0)
 ;;=2^VISUALLY IMPAIRED
 ;;^UTILITY(U,$J,358.3,1239,2)
 ;;=^295427
 ;;^UTILITY(U,$J,358.3,1240,0)
 ;;=250.01^^12^101^9
 ;;^UTILITY(U,$J,358.3,1240,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1240,1,1,0)
 ;;=1^250.01
 ;;^UTILITY(U,$J,358.3,1240,1,2,0)
 ;;=2^IDDM
 ;;^UTILITY(U,$J,358.3,1240,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,1241,0)
 ;;=250.00^^12^101^11
 ;;^UTILITY(U,$J,358.3,1241,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1241,1,1,0)
 ;;=1^250.00
 ;;^UTILITY(U,$J,358.3,1241,1,2,0)
 ;;=2^NIDDM
 ;;^UTILITY(U,$J,358.3,1241,2)
 ;;=^33605
 ;;^UTILITY(U,$J,358.3,1242,0)
 ;;=401.0^^12^101^6
 ;;^UTILITY(U,$J,358.3,1242,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1242,1,1,0)
 ;;=1^401.0
 ;;^UTILITY(U,$J,358.3,1242,1,2,0)
 ;;=2^HYPERTENSION MALIGNANT
 ;;^UTILITY(U,$J,358.3,1242,2)
 ;;=^73505
 ;;^UTILITY(U,$J,358.3,1243,0)
 ;;=796.0^^12^101^2
 ;;^UTILITY(U,$J,358.3,1243,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1243,1,1,0)
 ;;=1^796.0
 ;;^UTILITY(U,$J,358.3,1243,1,2,0)
 ;;=2^ABNORMAL LAB FINDINGS
 ;;^UTILITY(U,$J,358.3,1243,2)
 ;;=^273463
 ;;^UTILITY(U,$J,358.3,1244,0)
 ;;=305.1^^12^101^12
 ;;^UTILITY(U,$J,358.3,1244,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1244,1,1,0)
 ;;=1^305.1
 ;;^UTILITY(U,$J,358.3,1244,1,2,0)
 ;;=2^SMOKER
 ;;^UTILITY(U,$J,358.3,1244,2)
 ;;=^119899
 ;;^UTILITY(U,$J,358.3,1245,0)
 ;;=272.2^^12^101^10
 ;;^UTILITY(U,$J,358.3,1245,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1245,1,1,0)
 ;;=1^272.2
 ;;^UTILITY(U,$J,358.3,1245,1,2,0)
 ;;=2^MIXED HYPERLIPIDEMIA
 ;;^UTILITY(U,$J,358.3,1245,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,1246,0)
 ;;=401.9^^12^101^7
 ;;^UTILITY(U,$J,358.3,1246,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1246,1,1,0)
 ;;=1^401.9
 ;;^UTILITY(U,$J,358.3,1246,1,2,0)
 ;;=2^HYPERTENSION, ESSENTIAL
 ;;^UTILITY(U,$J,358.3,1246,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,1247,0)
 ;;=286.59^^12^101^5
 ;;^UTILITY(U,$J,358.3,1247,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1247,1,1,0)
 ;;=1^286.59
 ;;^UTILITY(U,$J,358.3,1247,1,2,0)
 ;;=2^HEM DISORDER D/T CIRC ANTICOAG
 ;;^UTILITY(U,$J,358.3,1247,2)
 ;;=^340504
 ;;^UTILITY(U,$J,358.3,1248,0)
 ;;=401.1^^12^101^8
 ;;^UTILITY(U,$J,358.3,1248,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1248,1,1,0)
 ;;=1^401.1
 ;;^UTILITY(U,$J,358.3,1248,1,2,0)
 ;;=2^HYPERTENSION,BENIGN
 ;;^UTILITY(U,$J,358.3,1248,2)
 ;;=^269591
 ;;^UTILITY(U,$J,358.3,1249,0)
 ;;=796.4^^12^101^1
 ;;^UTILITY(U,$J,358.3,1249,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1249,1,1,0)
 ;;=1^796.4
 ;;^UTILITY(U,$J,358.3,1249,1,2,0)
 ;;=2^ABNORMAL CLINICAL FINDINGS
 ;;^UTILITY(U,$J,358.3,1249,2)
 ;;=^273466
 ;;^UTILITY(U,$J,358.3,1250,0)
 ;;=250.80^^12^101^4
 ;;^UTILITY(U,$J,358.3,1250,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1250,1,1,0)
 ;;=1^250.80
 ;;^UTILITY(U,$J,358.3,1250,1,2,0)
 ;;=2^DIABETES TYPE II w/ SPEC MANIF
 ;;^UTILITY(U,$J,358.3,1250,2)
 ;;=^331811
 ;;^UTILITY(U,$J,358.3,1251,0)
 ;;=250.81^^12^101^3
 ;;^UTILITY(U,$J,358.3,1251,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1251,1,1,0)
 ;;=1^250.81
 ;;^UTILITY(U,$J,358.3,1251,1,2,0)
 ;;=2^DIABETES TYPE I w/ SPEC MANIF
 ;;^UTILITY(U,$J,358.3,1251,2)
 ;;=^331812
 ;;^UTILITY(U,$J,358.3,1252,0)
 ;;=368.8^^12^101^13
 ;;^UTILITY(U,$J,358.3,1252,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1252,1,1,0)
 ;;=1^368.8
 ;;^UTILITY(U,$J,358.3,1252,1,2,0)
 ;;=2^VISUAL DISTURBANCES NEC
 ;;^UTILITY(U,$J,358.3,1252,2)
 ;;=^88172
 ;;^UTILITY(U,$J,358.3,1253,0)
 ;;=V68.1^^12^102^16
 ;;^UTILITY(U,$J,358.3,1253,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1253,1,1,0)
 ;;=1^V68.1
 ;;^UTILITY(U,$J,358.3,1253,1,2,0)
 ;;=2^MEDICATION RENEWAL
 ;;^UTILITY(U,$J,358.3,1253,2)
 ;;=^295585
 ;;^UTILITY(U,$J,358.3,1254,0)
 ;;=V65.49^^12^102^15
 ;;^UTILITY(U,$J,358.3,1254,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1254,1,1,0)
 ;;=1^V65.49
 ;;^UTILITY(U,$J,358.3,1254,1,2,0)
 ;;=2^MEDICATION COUNSELING
 ;;^UTILITY(U,$J,358.3,1254,2)
 ;;=^303471
 ;;^UTILITY(U,$J,358.3,1255,0)
 ;;=250.92^^12^102^4
 ;;^UTILITY(U,$J,358.3,1255,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1255,1,1,0)
 ;;=1^250.92
 ;;^UTILITY(U,$J,358.3,1255,1,2,0)
 ;;=2^DIABETES W/UNSPEC COMP TYPE II
 ;;^UTILITY(U,$J,358.3,1255,2)
 ;;=^295722
 ;;^UTILITY(U,$J,358.3,1256,0)
 ;;=250.00^^12^102^3
 ;;^UTILITY(U,$J,358.3,1256,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1256,1,1,0)
 ;;=1^250.00
 ;;^UTILITY(U,$J,358.3,1256,1,2,0)
 ;;=2^DIABETES II
 ;;^UTILITY(U,$J,358.3,1256,2)
 ;;=^331779
 ;;^UTILITY(U,$J,358.3,1257,0)
 ;;=V67.51^^12^102^6
 ;;^UTILITY(U,$J,358.3,1257,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1257,1,1,0)
 ;;=1^V67.51
 ;;^UTILITY(U,$J,358.3,1257,1,2,0)
 ;;=2^HI-RISK RX F/U EXAM,NEC
 ;;^UTILITY(U,$J,358.3,1257,2)
 ;;=^295577
 ;;^UTILITY(U,$J,358.3,1258,0)
 ;;=V14.9^^12^102^9
 ;;^UTILITY(U,$J,358.3,1258,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1258,1,1,0)
 ;;=1^V14.9
 ;;^UTILITY(U,$J,358.3,1258,1,2,0)
 ;;=2^HX-DRUG ALLERGY NOS
 ;;^UTILITY(U,$J,358.3,1258,2)
 ;;=^295282
 ;;^UTILITY(U,$J,358.3,1259,0)
 ;;=V15.81^^12^102^8
 ;;^UTILITY(U,$J,358.3,1259,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1259,1,1,0)
 ;;=1^V15.81
 ;;^UTILITY(U,$J,358.3,1259,1,2,0)
 ;;=2^HX OF PAST NONCOMPLIANCE
 ;;^UTILITY(U,$J,358.3,1259,2)
 ;;=^295290
 ;;^UTILITY(U,$J,358.3,1260,0)
 ;;=401.9^^12^102^12
 ;;^UTILITY(U,$J,358.3,1260,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1260,1,1,0)
 ;;=1^401.9
 ;;^UTILITY(U,$J,358.3,1260,1,2,0)
 ;;=2^HYPERTENSION NOS
 ;;^UTILITY(U,$J,358.3,1260,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,1261,0)
 ;;=V58.61^^12^102^13
 ;;^UTILITY(U,$J,358.3,1261,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1261,1,1,0)
 ;;=1^V58.61
 ;;^UTILITY(U,$J,358.3,1261,1,2,0)
 ;;=2^L/T (CURRENT) USE - ANTICOAG
 ;;^UTILITY(U,$J,358.3,1261,2)
 ;;=^303459
 ;;^UTILITY(U,$J,358.3,1262,0)
 ;;=V65.19^^12^102^17
 ;;^UTILITY(U,$J,358.3,1262,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1262,1,1,0)
 ;;=1^V65.19
 ;;^UTILITY(U,$J,358.3,1262,1,2,0)
 ;;=2^PERSON CONSULT FOR ANOTH
 ;;^UTILITY(U,$J,358.3,1262,2)
 ;;=^329985
 ;;^UTILITY(U,$J,358.3,1263,0)
 ;;=272.4^^12^102^11
 ;;^UTILITY(U,$J,358.3,1263,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1263,1,1,0)
 ;;=1^272.4
 ;;^UTILITY(U,$J,358.3,1263,1,2,0)
 ;;=2^HYPERLIPIDEMIA NOS
 ;;^UTILITY(U,$J,358.3,1263,2)
 ;;=^87281
 ;;^UTILITY(U,$J,358.3,1264,0)
 ;;=285.29^^12^102^1
 ;;^UTILITY(U,$J,358.3,1264,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1264,1,1,0)
 ;;=1^285.29
 ;;^UTILITY(U,$J,358.3,1264,1,2,0)
 ;;=2^ANEMIA IN CHRONIC ILLNESS
 ;;^UTILITY(U,$J,358.3,1264,2)
 ;;=^334228
 ;;^UTILITY(U,$J,358.3,1265,0)
 ;;=585.6^^12^102^5
 ;;^UTILITY(U,$J,358.3,1265,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,1265,1,1,0)
 ;;=1^585.6
